Macrophages. dendritic cells and B-lymphocytes are sequentially recruited into the islets. serving as potent antigen presenting cells during the development of IDDM. This project will investigate the role of macrophages in the initiation of autoreactivity and islet cell damage. The efficient processing and presentation of autoantigens by macrophages is potentially a critical factor triggering pathogenesis. Engulfment of islet cell antigens by macrophages may lead to the generation of unique peptides which bind class II antigens and stimulate autoreactive T-cells. Studies of autoantigen presentation in humans have focussed on B- lymphocytes, yet little is known concerning the molecular steps which regulate antigen processing and presentation in macrophages. Antigen presenting cells may also regulate the progression of inflammatory responses, thus the influx of dendritic cells and later, B-lymphocytes into the pancreas may facilitate the presentation of new antigenic determinants. In support of this hypothesis, early T-lymphocyte responses are directed against a limited number of peptides derived from islet cell antigens followed by a broad spreading in T-cell reactivity with progression to IDDM. The overall goal of this project is to understand the molecular events which trigger immunological responses to islet cell antigens and the development of IDDM. For this purpose, the processing and presentation of an islet cell antigen, glutamic acid decarboxylase (GAD) will be studied in human macrophages, dendritic cells and B-lymphocytes. The initiation and amplification of autoimmune responses in IDDM, may be dependent upon the recruitment of specialized antigen presenting cells. Specifically, this proposal will test: 1) if macrophages, dendritic cells and B-lymphocytes differentially process the islet cell antigen GMD such that a distinct spectrum of antigenic peptides is produced within each of these APC; 2) if macrophages selectively display a unique series of GAD peptides bound to HLA class II antigens genetically linked with susceptibility to IDDM; 3) if macrophages preferentially activate early T-cell responses in prediabetes, while dendritic cells and B-lymphocytes are responsible for the spread of immunoreactivity with progression to IDDM. Insights into the relevant antigen presenting cells as well as the peptides derived from islet cell antigens, should prove useful in devising novel therapeutic interventions for IDDM.

Project Start
1998-06-01
Project End
1999-05-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Benaroya Research Institute at Virginia Mason
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98101
LaGasse, James M; Brantley, Michael S; Leech, Nicola J et al. (2002) Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 25:505-11
Nepom, G T; Lippolis, J D; White, F M et al. (2001) Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci U S A 98:1763-8
Ettinger, R A; Liu, A W; Nepom, G T et al. (2000) Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. J Immunol 165:3232-8
Kwok, W W; Liu, A W; Novak, E J et al. (2000) HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J Immunol 164:4244-9
McFarland, B J; Sant, A J; Lybrand, T P et al. (1999) Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. Biochemistry 38:16663-70
Reichstetter, S; Kwok, W W; Nepom, G T (1999) Impaired binding of a DQ2 and DQ8-binding HSV VP16 peptide to a DQA1*0501/DQB1*0302 trans class II heterodimer. Tissue Antigens 53:101-5
Huang, S C; Glas, A M; Pinchuk, G V et al. (1999) Human B cells accumulate immunoglobulin V gene somatic mutations in a cell contact-dependent manner in cultures supported by activated T cells but not in cultures supported by CD40 ligand. Clin Exp Immunol 116:441-8
Reijonen, H; Elliott, J F; van Endert, P et al. (1999) Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals. J Immunol 163:1674-81
Reichstetter, S; Kwok, W W; Kochik, S et al. (1999) MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition. Hum Immunol 60:608-18
Sanjeevi, C B; DeWeese, C; Landin-Olsson, M et al. (1997) Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus. Tissue Antigens 50:61-5

Showing the most recent 10 out of 17 publications